U.S. to end funding for child vaccines in developing countries, NY Times reports

The Trump administration intends to terminate the United States’ financial support for Gavi, the organization that has helped purchase critical vaccines for children in developing countries, saving millions of lives over the past quarter century, and to significantly scale back support for efforts to combat malaria, one of the biggest killers globally, The New York Times’s Stephanie Nolen reports. The administration has decided to continue some key grants for medications to treat H.I.V. and tuberculosis, and food aid to countries facing civil wars and natural disasters. Those decisions are included in a 281-page spreadsheet that the United States Agency for International Development sent to Congress Monday night, listing the foreign aid projects it plans to continue and to terminate. The New York Times obtained a copy of the spreadsheet and other documents describing the plans. Publicly traded vaccine maker companies include Moderna (MRNA), Novavax (NVAX), BioNTech (BTNX), Sanofi (SNY), Johnson & Johnson (JNJ), Pfizer (PFE), GSK (GSK), and AstraZeneca (AZN).